Last reviewed · How we verify
NCT05247138: BioRoot
Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
trial testing BioRootTM RCS in Root Canal Obturation in 142 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Septodont |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 142 |
| Start date | 18 February 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 1 July 2029 |
| Sites | 11 locations across France |
Drugs / interventions tested
- BioRootTM RCS
Conditions studied
- Root Canal Obturation — all drugs for Root Canal Obturation →
Sponsor
Septodont — full company profile →
Who can join
18 and older, any sex, with Root Canal Obturation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this retro-prospective Post-Market Clinical Follow-Up (PMCF) study is to collect long term clinical and safety data on root canal obturation after treatment, or retreatment, by BioRootTM RCS. The patients included in the study had received BioRootTM RCS 5 years ago. Participants will be followed prospectively at 5 and 10 years after root canal treatment. Clinical data, radiographic data, adverse events (safety) and device performance will be collected by the dentist from the inclusion visit until the end of the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05247138
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Root Canal Obturation
Currently open trials in the same condition.
- NCT07307807 — Evaluation of Postoperative Pain and Lesion Healing in Periapical Lesion-Affected Teeth Obturated With Different Root Ca · NA · active not recruiting
- NCT03732170 — Root Canal Treatment With TotalFill® Bioceramic Sealer and AH Plus® Sealer · NA · active not recruiting
Other Septodont trials
Trials by the same sponsor.
- NCT06955429 — Clinical Investigation Measuring the Long Term Clinical Performance and Safety of Biodentine™ XP in Patients Treated for · not yet recruiting
- NCT05536115 — Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket · completed
- NCT05614635 — Safety and Technical Performance of Plastalgin and Plastalgin Fast in Patients Requiring a Dental Impression · completed
- NCT05171231 — Performance and Safety of the Surgical Hemostatic Agent "HEMOCOLLAGENE®" in Patients Requiring Oral Surgery · completed
- NCT04945993 — Tooth Retention After Root Canal Treatment With Endomethasone N · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05247138 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Septodont
- Last refreshed: 3 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05247138.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing